Global Pharmacogenomics Within Precision Medicine: Challenges and Opportunities-Reference-Cited by-同舟云学术

Global Pharmacogenomics Within Precision Medicine: Challenges and Opportunities

Published:2019-11-06 Issue:1 Volume:107 Page:57-61
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Chenoweth Meghan J.¹²,Giacomini Kathleen M.³,Pirmohamed Munir⁴,Hill Susan L.⁵,Schaik Ron H.N.⁶,Schwab Matthias⁷⁸⁹,Shuldiner Alan R.¹⁰¹¹,Relling Mary V.¹²,Tyndale Rachel F.¹²¹³

Affiliation:

1. Campbell Family Mental Health Research Institute Centre for Addiction and Mental Health Toronto Ontario Canada

2. Department of Pharmacology and Toxicology University of Toronto Toronto Ontario Canada

3. Department of Bioengineering and Therapeutic Sciences University of California – San Francisco San Francisco California USA

4. Department of Molecular and Clinical Pharmacology Institute of Translational Medicine University of Liverpool Liverpool UK

5. National Health Service (NHS) London UK

6. Department of Clinical Chemistry Erasmus University Medical Center Rotterdam The Netherlands

7. Dr Margarete Fischer‐Bosch Institute of Clinical Pharmacology Stuttgart Germany

8. Department of Clinical Pharmacology and of Biochemistry and Pharmacy University of Tübingen Tübingen Germany

9. iFIT Cluster of Excellence University of Tübingen Tübingen Germany

10. Regeneron Genetics Center Regeneron Pharmaceuticals, Inc. Tarrytown New York USA

11. Program in Personalized and Genomic Medicine and Department of Medicine University of Maryland School of Medicine Baltimore Maryland USA

12. Pharmaceutical Sciences Department St Jude Children's Research Hospital Memphis Tennessee USA

13. Department of Psychiatry University of Toronto Toronto Ontario Canada

Funder

Canadian Institutes of Health Research

National Institutes of Health

Deutsche Forschungsgemeinschaft

Horizon 2020 Framework Programme

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.1664

Reference10 articles.

1. Research Directions in the Clinical Implementation of Pharmacogenomics: An Overview of US Programs and Projects

2. Genome-wide and candidate gene approaches of clopidogrel efficacy using pharmacodynamic and clinical end points—Rationale and design of the International Clopidogrel Pharmacogenomics Consortium (ICPC)

3. Genome-wide analysis of clopidogrel active metabolite levels identifies novel variants that influence antiplatelet response

4. Clinical Probes and Endogenous Biomarkers as Substrates for Transporter Drug-Drug Interaction Evaluation: Perspectives From the International Transporter Consortium

5. Implementation of genotype-guided dosing of warfarin with point-of-care genetic testing in three UK clinics: a matched cohort study

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessing the utility of measurement methods applied in economic evaluations of pharmacogenomics applications;Pharmacogenomics;2024-01-30

2. Circulating Biomarkers Instead of Genotyping to Establish Metabolizer Phenotypes;Annual Review of Pharmacology and Toxicology;2024-01-23

3. Single nucleotide polymorphisms and sickle cell disease-related pain: a systematic review;Frontiers in Pain Research;2023-09-14

4. Evaluating the prospective utility of pharmacogenetics reporting among Canadian Armed Forces personnel receiving pharmacotherapy: a preliminary assessment towards precision psychiatric care;BMJ Military Health;2023-09-01

5. Advancing CYP2D6 Pharmacogenetics through a Pharmacoequity Lens;Clinical Pharmacology & Therapeutics;2023-04-11